Department of Cardiology, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan.
Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan.
Heart Vessels. 2021 Aug;36(8):1151-1158. doi: 10.1007/s00380-021-01787-1. Epub 2021 Jan 24.
The aim of this study was to investigate the prevalence and prognostic value of coronary artery disease (CAD) and heart failure (HF) in patients with idiopathic pulmonary fibrosis (IPF). Thirteen hundred and fifty-eight patients with interstitial lung disease [851 (62%) males, mean age: 68 ± 10 years] were retrospectively analyzed. CAD was defined as (1) the presence of a clinical diagnosis of angina pectoris, (2) clinical diagnosis of a myocardial infarction, and (3) coronary angiography showing ≥ 1 vessel with a stenosis of > 75%. The definition of HF was made according to the modified Framingham criteria. Compared to the non-IPF group (n = 790), the IPF group (n = 568) had a significantly higher prevalence of CAD (9.3% vs. 4.4%, p < 0.001) and HF (8.2% vs. 3.7%, p < 0.001). During a median follow-up of 1.6 years, 152 deaths were identified. The patients with HF had a significantly worse prognosis than those without HF both in the non-IPF group and IPF group (both p < 0.05). However, the prognosis did not significantly differ between the patients with CAD and those without CAD both in the non-IPF group and IPF group. The presence of HF was an independent predictor of death in the IPF [hazard ratio (HR) 3.67, 95% confidence interval (CI) 1.57-8.56, p = 0.0025] and non-IPF (HR 5.07, 95% CI 1.44-17.86, p = 0.011) patients. The prevalence of CAD and HF was significantly higher in IPF than non-IPF patients. In addition, the presence of HF was a significant prognostic factor for both IPF and non-IPF patients. These results indicated that the importance of HF as a comorbidity for patients with ILD.
本研究旨在探讨特发性肺纤维化(IPF)患者中冠状动脉疾病(CAD)和心力衰竭(HF)的患病率及其预后价值。回顾性分析了 1358 例间质性肺疾病患者[851 例(62%)为男性,平均年龄:68±10 岁]。CAD 的定义为:(1)存在心绞痛的临床诊断,(2)临床诊断心肌梗死,和(3)冠状动脉造影显示≥1 支血管狭窄>75%。HF 的定义根据改良的Framingham 标准。与非 IPF 组(n=790)相比,IPF 组(n=568)CAD(9.3%比 4.4%,p<0.001)和 HF(8.2%比 3.7%,p<0.001)的患病率显著更高。在中位随访 1.6 年期间,共确定了 152 例死亡。HF 患者在非 IPF 组和 IPF 组的预后均显著差于无 HF 患者(两组均 p<0.05)。然而,在非 IPF 组和 IPF 组中,CAD 患者与无 CAD 患者的预后差异无统计学意义。HF 的存在是非 IPF 组(危险比 [HR] 3.67,95%置信区间 [CI] 1.57-8.56,p=0.0025)和 IPF 组(HR 5.07,95%CI 1.44-17.86,p=0.011)患者死亡的独立预测因素。与非 IPF 患者相比,IPF 患者中 CAD 和 HF 的患病率显著更高。此外,HF 的存在是非 IPF 和 IPF 患者的重要预后因素。这些结果表明 HF 作为 ILD 患者合并症的重要性。